Cannabis and cannabinoids in synergy: a possible panacea for head pain
ENFLEUR would like to share recent review of the medical literature that included cannabis’ and cannabinoids’ therapeutic potential in treating migraines, facial pain, and headaches, and other chronic pain syndromes, as well as the medical literature on the synergistic effects of major and minor cannabinoids, flavonoids, a type of plant pigment, and primary and secondary terpenes, which can be most straightforwardly understood as a component of a plant’s essential oils. Published in the peer-reviewed medical journal Headache: the Journal of Head and Face Pain, the review finds that the assemblage of research that evidences that cannabis and cannabinoids are beneficial in treating pain implies that cannabis and cannabinoids may also be an effective treatment option for migraines and headaches. The review also expects that, based on cursory findings, additional research will be conducted in order to optimize the synergistic activity of cannabinoids, terpenes, and other phytochemicals within certain strains to enhance its therapeutic efficacy. In the meanwhile, incorporating a high quality broad spectrum or full spectrum CBD product into a wellness regime can be beneficial for those living with migraines, facial pain, headaches, and other chronic pain syndromes.
Why does this matter? Accumulating evidence for the efficacy of cannabis and cannabinoids in the treatment of various pain syndromes may carry over to the treatment of headaches and migraines.